Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

BACKGROUND: The aims of this analysis were to investigate treatment completion and adherence among people with ongoing injecting drug use or receiving opioid substitution therapy (OST) in a study of response-guided therapy for chronic HCV genotypes 2/3 infection. METHODS: ACTIVATE was a multicenter...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunningham, Evan B., Hajarizadeh, Behzad, Dalgard, Olav, Amin, Janaki, Hellard, Margaret, Foster, Graham R, Bruggmann, Philip, Conway, Brian, Backmund, Markus, Robaeys, Geert, Swan, Tracy, Marks, Philippa S., Quiene, Sophie, Applegate, Tanya L, Weltman, Martin, Shaw, David, Dunlop, Adrian, Bruneau, Julie, Midgard, Håvard, Bourgeois, Stefan, Thurnheer, Maria Christine, Dore, Gregory J, Grebely, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470219/
https://www.ncbi.nlm.nih.gov/pubmed/28610605
http://dx.doi.org/10.1186/s12879-017-2517-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470219/
https://www.ncbi.nlm.nih.gov/pubmed/28610605
http://dx.doi.org/10.1186/s12879-017-2517-3

Ejemplares similares